Basic Information
Dosis is an AI-based personalized dosing platform and the developer of the Strategic Anemia Advisor (SAA) clinical decision support tool. SAA is currently revolutionizing anemia management for over 5,000 dialysis patients across more than 50 dialysis clinics in China, assisting healthcare providers in determining patients' unique responses to erythropoiesis-stimulating agents (ESA) and recommending personalized doses to keep individual patients within their hemoglobin target range.
Dosis, Inc.
SanFrancisco,California,United States of America
less than 15 people
January 01, 2017
--
hello@dosisinc.com

